September 2022 - Page 23 of 26

WednesdaySep 07, 2022 1:51 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at H.C. Wainwright 24th Annual Global Investment Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that its CEO John Climaco will present at the H.C. Wainwright 24th Annual Global Investment Conference. The event is being held in New York, New York, and virtually on Sept. 12-14, 2022. A video webcast of the presentation will be accessible for viewing on-demand beginning at 7:00 a.m. ET on Sept. 12 for those registered for the event. The webcast will also be available on the Events page of the company’s website,…

WednesdaySep 07, 2022 1:10 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Partners with UYS, Marks Entry into CEA Space

Correlate Infrastructure Partners (OTCQB: CIPI), a technology-enabled energy optimization and clean energy solutions provider for the U.S. commercial real estate industry, today announced its partnership with Ultra Yield Solutions (“UYS”) to address high energy use -- the most cost prohibitive aspect of indoor growing facilities. The premier horticultural lighting distributor, UYS focuses on LED lighting technology and energy management solutions for controlled environment agriculture (“CEA”) facilities. According to the update, the collaboration marks Correlate’s entrance into the CEA space and provides a unique service offering that enhances the sustainability and profitability of indoor farming operations. “We are excited to see…

WednesdaySep 07, 2022 11:30 am

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Subsidiary Announces Acquisition of Emerging Hemp Flower Market Brand

Flora Growth (NASDAQ: FLGC), an all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, announced that its wholly owned subsidiary, Just Brands LLC, has acquired substantially all of the assets related to the No Cap Hemp Co. brand. The company anticipates that the acquisition of this emerging brand in the hemp flower market will diversify its brand portfolio and product offerings as well as create an opportunity to expand Flora’s distribution foothold in the United States by providing a unique collection of products with strong revenue growth potential. According to the announcement, the acquisition will offer Flora an…

WednesdaySep 07, 2022 11:15 am

Odyssey Health, Inc. (ODYY) Receives Approval to Proceed with Cohort II of Its Phase I Trial’s Multiday Ascending Dosing Stage

Medical company Odyssey Health has received approval from the Safety Review Committee to start Cohort II of its Phase I trial’s Multiday Ascending Dosing (“MAD”) stage The approval follows evidence that Odyssey’s PRV-002 concussion drug candidate was safe and well-tolerated, as seen in Cohort I of the MAD stage The pharmacokinetic analysis also supports the hypothesis that more drug is getting to the brain itself, backing the company’s use of its patent-pending breath-propelled intranasal drug administration device The company believes that the intranasal drug/delivery combination will be instrumental in the success of the PRV-002 drug candidate in planned Phase II/III…

WednesdaySep 07, 2022 11:07 am

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) CEO Makes Top-100 Innovation List, Company Postpones Meet Delic Event

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) CEO Matt Stang was included in World Biz magazine’s Top-100 CEOs in Innovation for 2022. The announcement noted that Stang was recognized as a champion of creativity who is dedicated to making a positive environmental and social impact. Stand cofounded Delic Corp., which has grown into a leader in new medicines and treatments for a modern world. Stang led the company’s acquisition of the Ketamine Wellness Centers, and under his guidance, the company reported more than $1.5 million in total revenue in 2021 while more than quadrupling its net assets. This month, Stang…

WednesdaySep 07, 2022 10:30 am

Correlate Infrastructure Partners Inc.’s (CIPI) CEO, Todd Michaels, Acknowledges the Company’s Organic Growth; Notes that it Has Never Been a Better Time for Business

Todd Michaels, Correlate’s Founder, President, and CEO, appeared on the latest episode of the Bell2Bell Podcast, where he talked about the company’s background, its achievements so far, and what lies ahead Mr. Michaels highlighted the opportunity in solar power generation, acknowledging that by 2050, it should account for around 40% of the actual overall capacity of energy generation in North America He also cited the Inflation Reduction Act, which adds incentives that are expected to help drive a significant leap forward for Correlate He was keen to point out that the company’s future looks bright and even maintained potential revenue…

WednesdaySep 07, 2022 10:25 am

QualityStocksNewsBreaks – EverGen Infrastructure Corp.’s (TSX.V: EVGN) (OTCQB: EVGIF) Upside Potential Featured in Seeking Alpha Article

EverGen (TSX.V: EVGN) (OTCQB: EVGIF) was featured in a recent Seeking Alpha article describing its positioning to take advantage of tremendous opportunities as the world shifts to renewable energy sources to fight climate change and government officials spend billions on building this infrastructure. The piece describes EverGen as “a leading Canadian pure-play in the renewable natural gas (“RNG”) space with significant growth prospects, including pumping up its EBITDA from $3 million to $50 million in the next two to three years with its ongoing project pipelines. The stock’s upside potential is significantly higher than the downside risks because of the…

WednesdaySep 07, 2022 9:45 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Posts Slight Q2 2022 Performance Improvement; Maintains Priorities and Focus on Advancing its Clinical Development Program for Berubicin

CNS reported a decrease in losses from $3.8 million in Q2 2021 to $3.6 million in Q2 2022, as well as a drop in research and development expenses from $2.7 million to $2.2 million, with an increase in general and administrative expenses from $1.1 million to $1.3 million The company closed the quarter with $9.0 million in cash, and a working capital of approximately $10.3 million which, it is confident, will fund its operations into the 2023 calendar year CNS looks to continue site initiations across the U.S., Italy, France, Spain, and Switzerland, while also pushing for regulatory and ethics…

WednesdaySep 07, 2022 9:00 am

FingerMotion Inc. (NASDAQ: FNGR) Benefitting From a First-Mover Advantage, and Relationships Forged in the Chinese Market

Martin Shen, FingerMotion’s CEO, noted the company’s shift in focus to pushing gross margins higher for the 2022 calendar year This has shaped the company’s initiatives that have seen the addition of the mobile device protection service for the Chinese market Since launching the service, FingerMotion has received $4 million in funding from Lind Global Fund II, LP, and is confident that this investment will yield the highest return, strengthen the company’s balance sheet, and enable it to experience transformational revenue growth over the next 12-24 months Mr. Shen has maintained that the current revenue is just “the tip of…

Site Search

Company Search

Month: September 2022